SUMMARY A 54 year old man with refractory life threatening ventricular tachycardia was given an automatic defibrillator. The initial system was a transvenous defibrillator coil electrode and this was later modified by implantation of two patch electrodes at thoracotomy.
Internal defibrillators have been introduced to treat refractory and repeated ventricular tachycardia or fibrillation. We describe a patient in whom cardiac arrest was caused by ventricular fibrillation. A defibrillator was implanted four years after myocardial infarction.
Case report
In 1979, when he was 50, this man had had an inferoposterior myocardial infarction which was complicated with late ventricular tachycardia and cerebral embolism. Treatment with disopyramide was started and this was later changed to amiodarone (400 mg/day) on the basis of Holter tape recordings which consistently showed frequent ventricular extrasystoles and couplets. He -10°, QRS width of 0-10 s, Q wave in lead III, and QR duration of 0.38 s.
Serum electrolytes and creatinine and blood glucose concentrations were within the normal range. Serum aspartate aminotransferase activity was 113 IU/l (normal 11-33 IU/1), lactic dehydrogenase was 425 IU/l (normal 200-400 IU/1), and creatine kinase was 51 IU/l (normal 0-150 IU/1) immediately after admission. Serum creatine kinase concentration reached a peak (268 IU/1) eight hours after admission but the MB fraction remained below 9 IU/1. A chest x ray film showed cardiomegaly with bilateral pulmonary venous congestion.
A coronary angiogram showed a proximal occlusion of the right coronary artery. An occlusion of the middle part of the circumflex artery was bridged by an extensive collateral circulation and there was a mild stenosis of the first diagonal artery of the left anterior descending artery. The inferior wall was akinetic. A left ventricular angiogram did not show any septal defect or mitral regurgitation. Ejection fraction, as measured with radionuclides was 42%. Four weeks later a basic electrophysiological study was performed. Stimuli were delivered by a Jansen stimulator at a constant current of < 1 mA with pulse width of 2 ms. Stimulation was applied above the right ventricular apex. Sustained hypotensive ventricular tachycardia with a cycle length of 240 ms was produced when double stimuli were applied to the heart in sinus rhythm. Rhythm was easily reproduced with double stimuli on a ventricular driven rhythm of 110 beats per minute.
In the subsequent serial drug testing procedure, intravenous procainamide on its own (16 pg/ml and 6-5 jig/ml) was ineffective in preventing stimulated 606 tachycardia and it was still possible to induce ventricular tachycardia or fibrillation with the original stimulation protocol when the patient was on beta blockers or tocainide. After three weeks loading with oral amiodarone, ventricular fibrillation could still be easily induced by double stimuli on a paced rhythm of 90 beats per minute, and this situation was unchanged when amiodarone was given in combination with oral mexiletine. When amiodarone was given in combination with procainamide induction of fibrillation was slightly more difficult and double stimuli given on a basic rhythm of 110 beats per minute produced a hypotensive ventricular tachycardia of 150 beats per minute. Hence, the patient was started on oral procainamide (1-5 g three times a day) in combination with amiodarone (600 mg). This regimen was not considered to be effective because Holter tracings showed multiform ventricular premature beats and the patient had gastrointestinal symptoms and a productive cough. On 11 April 1984 an automatic implantable defibrillator (AID-BR) (Intec Systems, Pittsburgh, USA) was implanted under general anaesthesia. A bipolar electrode was passed through the left cephalic vein and placed in the right ventricular apex. The amplitude of the R wave was 12 mV. The Seldinger technique was used to place a classic defibrillator coil in the superior caval vein and a subxiphoid incision Jordaens, Hamerlynck, Clement was made prepartory to positioning of a defibrillation patch.
Ventricular tachycardia with a cycle length of 320 ms could be induced with programmed electrical stimulation and could be stopped repeatedly with 5 J delivered through an external device (Fig. 1) . In an attempt to induce ventricular fibrillation with programmed stimulation, however, ventricular tachycardia was induced by a burst of stimulation and when 20 J was delivered by the external cardioverter-defibrillator through the coil and patch the tachycardia rate was increased. A further shock of 30 J stopped the tachycardia. Extemal cardioversion was needed to terminate ventricular fibrillation.
Anterolateral left thoracotomy was carried out so that a large defibrillation patch and a small defibrillation patch could be positioned in the pericardial space. The defibrillation threshold for ventricular fibrillation was <20 J. With the impulse generator in the abdominal pouch, fibrillation was produced by application of an alternating current. After a charge time of 8-2 s, a first shock of 25-5 J was given after another 14 seconds. A third shock was needed to convert the ventricular fibrillation to sinus rhythm. Fig. 1 Efficacy of defibrillator during monomorphous ventricular tachycardia. At implantation mononorphous tachycardia (cycle length 340ms) was interrupted by a 5J shock between a coil in the superior caval vein and a patch in the pericardial space (SCV-P). Ventricularfibrillation, however, was not terminated by 351 shock. RV, bipolar electrode in right ventricle.
Paper speed was 25 mmls. 
was terminated by the first shock. Termination of a recurrence required two internal shocks.
The patient was discharged in excellent condition, without antiarrhythmic drugs. Because we feared that the threshold of the defibrillator for ventricular fibrillation might be too high, a control electrophysiological study was performed on 25 May. Ventricular monomorphous tachycardia with cycle length of 330 ms was induced by double stimuli on a basic paced rhythm of 110 beats per minute. It was instantaneously detected and corrected by the first shock.
When a second episode of ventricular tachycardia terminated spontaneously a shock was given 290 ms after the P wave, and this produced long lasting atrial fibrillation and a ventricular rate of 100 beats per minute (Fig. 2) . Ventricular fibrillation was produced by application of alternating current (50 Hz) for 2s and the first shock of 25 5 J converted both rhythms to sinus rhythm. The patient was discharged after 24 hours. He is back at work.
Discussion
Ventricular fibrillation causes most sudden deaths from heart disease.' The speed with which ventricular fibrillation can be terminated by defibrillation seems to be an important factor in determining the success of cardiopulmonary resuscitation,2 and an automatic implantable device that detects and corrects ventricular fibrillation immediately will be of considerable benefit in high risk patients. Such a I II aVF device has been developed and implanted in more than 250 patients.3~5
The clinical results are good, with a 25% decline in mortality at one year.5 These results were obtained in patients with older units and before the use of two patches or larger patches had been considered.34 The 12 month survival rate in patients fitted with defibrillators is reported to be as high as 97-2% from ventricular tachycardia or fibrillation; it is 83-4% from all types of cardiovascular disease. These results show that implantable defibrillators are better than other forms of treatment for refractory ventricular rhythm disturbances. 5 Much research has been done on the ideal positioning and size of the paddles and on the amount and character of the energy delivered to the myocardium.6 These studies led to the concept of a defibrillation threshold-that is the application of an appropriate amount of energy to the myocardium for a critical time. 6 The sensing and defibrillation thresholds must be adjusted during implantation of the device. This influences the surgical technique and is relevant to previous and intended operations .7 If no other cardiovascular surgery is performed at the time of implantation, it is possible to insert the apical electrode through a small subxiphoid incision, as was our intention.8 This case report, however, confirms that some patients may show a high defibrillation threshold during the operation, or may even go into ventricular fibrillation when defibrillatory shocks are given. The conversion rate with the original spring patch defibrillator for mono-071 0- Fig. 2 Electrophysiological study after implantation of defibrillator. The induced regular ventricular tachycardia terminated spontaneously but was sensed (arrow at point ofdetection) by the defibrillator before sinus rhythm returned. An internal shock given 290 
